L934-0255 Screening compound: 2-(4-fluorophenoxy)-N-{5-[1-(4-fluorophenyl)-5-oxotetrahydro-1H-pyrrol-3-yl]-1,3,4-oxadiazol-2-yl}acetamide

L934-0255 Screening compound: 2-(4-fluorophenoxy)-N-{5-[1-(4-fluorophenyl)-5-oxotetrahydro-1H-pyrrol-3-yl]-1,3,4-oxadiazol-2-yl}acetamide
L934-0255 Screening compound: 2-(4-fluorophenoxy)-N-{5-[1-(4-fluorophenyl)-5-oxotetrahydro-1H-pyrrol-3-yl]-1,3,4-oxadiazol-2-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L934-0255
2-(4-fluorophenoxy)-N-{5-[1-(4-fluorophenyl)-5-oxotetrahydro-1H-pyrrol-3-yl]-1,3,4-oxadiazol-2-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L934-0255

Molecular Formula

C20H16F2N4O4 (C20 H16 F2 N4 O4)

Compound Name

2-(4-fluorophenoxy)-N-{5-[1-(4-fluorophenyl)-5-oxotetrahydro-1H-pyrrol-3-yl]-1,3,4-oxadiazol-2-yl}acetamide

IUPAC name

2-(4-fluorophenoxy)-N-{5-[1-(4-fluorophenyl)-5-oxopyrrolidin-3-yl]-134-oxadiazol-2-yl}acetamide

SMILES

O=C(COc(cc1)ccc1F)Nc1nnc(C(CC2=O)CN2c(cc2)ccc2F)o1

InChI

InChI=1S/C20H16F2N4O4/c21-13-1-5-15(6-2-13)26-10-12(9-18(26)28)19-24-25-20(30-19)23-17(27)11-29-16-7-3-14(22)4-8-16/h1-8,12H,9-11H2,(H,23,25,27)

InChI Key

YABPFENDVGQKMI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27488331

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.37

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.068

Distribution Coefficient, logD

1.663

Water Solubility, LogSw

-2.83

Polar Surface Area

79.194

Acid Dissociation Constant (pKa)

7.21

Base Dissociation Constant (pKb)

-2.79

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.00

L934-0255 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Others
  • Kinases
Mechanism of action:
  • Epigenetic
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L934-0255 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L934-0255?
Check Price and Availability of L934-0255, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L934-0255 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L934-0255
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L934-0255
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L934-0255 available by request